Financials
- Market Capitalization 439.42 M
- Employee 23
- Founded 2014
- CEO N/A
- Website www.ovidrx.com
- Headquarter Delaware, United States
- FIGI BBG009F0TD76
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-7.09
Relación precio/flujo de caja
16.57
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2924 | ENTX Entera Bio Ltd. - Ordinary Shares | 2.57 USD | -3.02% | -1.53% | -8.54% | +0.78% | 444.97 M USD | ||
| 2943 | SLN Silence Therapeutics Plc - American Depository Share | 9.31 USD | -3.52% | -6.81% | -27.60% | +65.66% | 439.87 M USD | ||
| 2949 | AUTL Autolus Therapeutics plc - American Depositary Shares | 1.64 USD | -5.75% | -8.89% | -11.83% | +3.14% | 436.51 M USD | ||
| 2957 | PRTA Prothena Corporation plc - Ordinary Shares | 8.41 USD | -0.24% | +4.47% | -6.03% | -18.51% | 431.74 M USD |